- Report
- August 2023
- 319 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- May 2023
- 309 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- March 2024
- 196 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- May 2024
- 184 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- March 2024
- 186 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- March 2024
- 196 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- May 2024
- 192 Pages
Global
From €5248EUR$5,450USD£4,514GBP
- Report
- May 2024
- 306 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- May 2024
- 196 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 188 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- January 2024
- 181 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- October 2023
- 190 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- July 2023
- 116 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Report
- February 2024
- 120 Pages
Global
From €4574EUR$4,750USD£3,934GBP
The Bone Marrow market is a subset of the biotechnology industry that focuses on the development of treatments and therapies for diseases related to the bone marrow. This includes treatments for blood cancers such as leukemia, lymphoma, and multiple myeloma, as well as treatments for bone marrow failure syndromes. Bone marrow transplants are also used to treat a variety of other conditions, such as sickle cell anemia and thalassemia.
The Bone Marrow market is driven by advances in biotechnology, such as gene therapy, stem cell research, and immunotherapy. These technologies have enabled researchers to develop more effective treatments for bone marrow-related diseases. Additionally, the increasing prevalence of these diseases has created a demand for new treatments and therapies.
Some companies in the Bone Marrow market include Celgene, Gilead Sciences, Novartis, and Kite Pharma. These companies are involved in the development of treatments and therapies for bone marrow-related diseases, as well as the production of bone marrow transplants. Show Less Read more